In the last trading session, 9.17 million shares of the Entero Therapeutics Inc (NASDAQ:ENTO) were traded, and its beta was 1.00. Most recently the company’s share price was $0.61, and it changed around $0.12 or 23.31% from the last close, which brings the market valuation of the company to $2.90M. ENTO currently trades at a discount to its 52-week high of $9.35, offering almost -1432.79% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 68.85% since then.
Entero Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended ENTO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Entero Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
Entero Therapeutics Inc (NASDAQ:ENTO) trade information
Instantly ENTO has showed a green trend with a performance of 23.31% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8989 on recent trading dayincreased the stock’s daily price by 32.14%. The company’s shares are currently down -1.93% year-to-date, but still up 26.82% over the last five days. On the other hand, Entero Therapeutics Inc (NASDAQ:ENTO) is 22.02% up in the 30-day period.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 73.53%.
ENTO Dividends
Entero Therapeutics Inc’s next quarterly earnings report is expected to be released in April.
Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 15.05 shares worth $9183.0, making up 0.32% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 4.54 shares worth around $2766.0, which represents about 0.10% of the total shares outstanding.
